相关实验视频

Updated: Jun 28, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

针对晚期肝内胆固醇癌的系统治疗的最新进展

Changhoon Yoo¹, Jaewon Hyung¹, Stephen L Chan²

¹Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

|April 19, 2024

概括

肝脏内胆管癌 (IHCCA) 的全身治疗方法正在进步,新的一线,二线和向疗法显示出前景. 然而,治疗耐药性仍然是一个挑战,需要进一步的研究以改善患者的治疗结果.

科学领域:

在瘤学瘤学.
肝胆道手术肝胆道手术
医学胃肠道学医学胃肠道学

背景情况:

肝脏内胆管癌 (IHCCA) 发病率在全球范围内不断增加,这对健康构成重大挑战.
先进的IHCCA通常表现为系统性疾病,使系统性治疗至关重要.
本综述侧重于IHCCA系统治疗的最新进展.

研究的目的:

审查针对晚期肝内胆管癌的全身疗法的近期进展.
突出目前的一线,二线和有针对性的治疗选择.
讨论IHCCA系统治疗中的挑战和未来方向.

主要方法:

审查最近的临床试验和IHCCA系统治疗的指导方针.
分析了TOPAZ-1,ABC-06和NIFTY等关键试验的数据.
针对IHCCA的特定基因组变化的向剂的检查.

主要成果:

杜尔瓦卢马布与吉姆西塔和西斯普拉丁结合是一种推的第一线治疗,改善整体存活率.
对于没有可行的改变的患者,二线选择包括光皮里米丁加氧沙或纳米脂体内氨基酸.
针对性疗法对具有特定基因组变异 (FGFR2,IDH1,BRAF,ERBB2) 的IHCCA显示出有效性.

结论:

最近的全身治疗改善了先进的IHCCA患者的治疗结果.
治疗耐药性和瘤在一年内进展是重大挑战.
进一步的研究是必不可少的,以提高治疗疗效和克服在先进的IHCCA.抗药性.

关键词:

胆道通道中的胆道通道.霍兰基细胞癌 (Cholangiocellular carcinoma) 是一种细胞癌.分子向疗法分子向疗法系统化疗是一种全身化疗.治疗方法治疗方法

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...